Download PDF
Thromb Haemost 2001; 86(05): 1334
DOI: 10.1055/s-0037-1616071
Letters to the Editor
Schattauer GmbH

Antiphospholipid Antibodies, Portal and Mesenteric Thrombosis and Carcinoid Tumor: A Case Report

A. Aranguren
1   Hematology Service, University Clinic of Navarra, Pamplona, Spain
,
M. Pérez-Salazar
1   Hematology Service, University Clinic of Navarra, Pamplona, Spain
,
J. A. Páramo
1   Hematology Service, University Clinic of Navarra, Pamplona, Spain
,
J. Zozaya
2   Digestive Service, Hospital of Navarra, Pamplona, Spain
,
E. Rocha
1   Hematology Service, University Clinic of Navarra, Pamplona, Spain
› Author Affiliations
Further Information

Publication History

Received 27 March 2001

Accepted after resubmission 31 July 2001

Publication Date:
13 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Sorensen HT, Mellemkjaer L, Steffensen HF, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998; 338: 1169-73.
    CrossrefPubMedGoogle Scholar
  • 2 Baron JA, Gridley G, Weiderpass E, Nyrén O, Linet M. Venous thromboembolism and cancer. Lancet 1998; 351: 1077-80.
    CrossrefPubMedGoogle Scholar
  • 3 Bax NDS, Woods HF, Batchelor A, Jennings M. Clinical Manifestations of Carcinoid Disease. World J Surg 1996; 20: 142-6.
    CrossrefPubMedGoogle Scholar
  • 4 Anderson AS, Krauss D, Lang R. Cardiovascular complications of malignant carcinoid disease. Am Heart J 1997; 134: 693-702.
    CrossrefPubMedGoogle Scholar
  • 5 Miura K. Primary carcinoid tumour of the liver. Am J Clin Path 1988; 89: 561-4.
    CrossrefPubMedGoogle Scholar